We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

RGLS

7.915 USD
0.035
0.44%
Last update May 21, 11:35 AM EDT
Main market
Day range
7.89
7.925
Previous close
7.95000
Open
7.89
Access this stock data via API
Subscribe
Regulus Therapeutics Inc.
7.92
0.04
0.44%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 0 0 0 0
Cost of revenue
Gross profit
Operating expense
Research & development 35.4M 21.2M 18.4M 17.8M
Selling general and admin 14.7M 10.0M 9.8M 10.0M
Other operating expenses
Operating income -50.0M -31.1M -28.2M -27.8M
Non operating interest income
Income 3.8M 1.7M 605K 864K
Expense 158K 604K 688K 855K
Other income expense
Pretax income -46.4M -30.0M -28.3M -27.8M
Tax provision 1K 1K 1K 1K
Net income -46.4M -30.0M -28.3M -27.8M
Basic EPS -0.8 -1.6 -1.9 -3.2
Diluted EPS -0.8 -1.6 -1.9 -3.2
Basic average shares 56.3M 19.0M 15.3M 8.6M
Diluted average shares 56.3M 19.0M 15.3M 8.6M
EBITDA -45.9M -29.2M -27.5M -26.5M
Net income from continuing op. -46.4M -30.0M -28.3M -27.8M
Minority interests
Preferred stock dividends
Main market

Exchange is currently active.
Closing in 4 hours 23 minutes

11:36
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).